Published 13:26 IST, December 10th 2020
UK regulators warn people with significant allergic reactions to refrain from inoculation
UK regulators have warned that people with a history of “significant” allergic reactions should refrain from Pfizer-BioNTech COVID-19 jab.
Advertisement
UK regulators have warned that people with a history of “significant” allergic reactions should refrain from Pfizer-BioNTech COVID-19 jab. warning comes after two of initial patients who were iculated suffered reactions. In aftermath, both patients were sent to immediate treatment and are fine w, an NHS professional confirmed AP.
As per BBC, both of m were NHS workers, having a history of serious allergies and carried renaline pens with m. Both of m are believed to have h an anaphylactoid reaction, which involved person getting a skin rash, breathlessness and occasionally drop in blood pressure. Doctors have opined reaction to be n-fatal.
Advertisement
chief executive of UK regulatory body informed lawmakers about two cases and said that allergies were t reported during extensive trial of vaccine before approval. Pfizer and BioNTech have said that y are in touch with NHS and are looking into each case individually to identify cause. document published by two companies also suggested that allergic people were t included in trials.
Advertisement
British regulators approved Pfizer's COVID-19 vaccine on December 2, making way for first vaccination drive in West. UK has set-up over 50 vaccination centres across country and has also issued guidance for health practitioners about coronavirus (COVID-19) vaccination programme. High-risk groups including doctors and or frontline workers have been prioritised for vaccination drive that is being run by National Health Service (NHS).
Advertisement
People with underlying health conditions, children, and pregnant women have been left out of vaccination drive in United Kingdom due to data on safety of COVID-19 vaccines on se groups. government has reportedly received 8,00,000 doses of Pfizer's vaccine, which should be eugh for 4,00,000 people given two-dose process recommended by firm. As per reports, UK is expected to receive ditional doses of vaccine by end of this year.
Advertisement
13:26 IST, December 10th 2020